Combined immune checkpoint blockade as a therapeutic strategy for BRCA1-mutated breast cancer. (Q48311135)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Combined immune checkpoint blockade as a therapeutic strategy for BRCA1-mutated breast cancer. |
scientific article |
Statements
Combined immune checkpoint blockade as a therapeutic strategy for BRCA1-mutated breast cancer. (English)
1 reference
Antonia N Policheni
Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab)
1 June 2017
1 reference
1 reference